Dextran-MLDH-fluorouracil super-molecular skeleton magnetic liposome
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- NINGXIA MEDICAL UNIV
- Publication Date
- 2015-06-03
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of development of modern drug delivery systems and preparations thereof, and specifically relates to a magnetic liposome DMFL with the "dextran-MLDH-fluorouracil" supramolecular drug delivery system DMF as the core skeleton, which is suitable for anticancer drug magnetically targeted chemotherapy. Processing and production of magnetic liposomes are required. Background technique
[0002] Fluorouracil is a broad-spectrum antineoplastic drug, which is often used in the treatment of gastrointestinal tumors, breast cancer, ovarian cancer and other diseases. Side effects such as bone marrow suppression.
[0003] Liposome is a phospholipid bilayer microcapsule similar in structure to the cell membrane. It has the advantages of slow release, low toxicity, biocompatibility, good drug solubility, etc., and the possibility of targeted transformation and comprehensive processing. Therefore, it has become In recent years, the r...